Barchart.com
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Defence Therapeutics Inc (DTCFF)

Defence Therapeutics Inc (DTCFF)
0.6447 -0.3517 (-35.30%) 04/10/25 [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
News & Headlines for Thu, Apr 10th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies Newsfile - Tue Apr 8, 2:26AM CDT

Montreal, Quebec--(Newsfile Corp. - April 8, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing advanced...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence Announces US Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Defence's Management Team as Chief Operating Officer Newsfile - Wed Mar 26, 2:26AM CDT

Montreal, Quebec--(Newsfile Corp. - March 26, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million Newsfile - Fri Jan 31, 5:02PM CST

Montreal, Quebec--(Newsfile Corp. - January 31, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence to Connect with Industry Leaders and Potential Partners During the JP Morgan Healthcare Conference in San Francisco. Plans to Expand the Next Generation of Radio-Immuno Conjugates in 2025 Newsfile - Fri Jan 10, 3:42PM CST

Montreal, Quebec--(Newsfile Corp. - January 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company") a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence Fortifies Patent Portfolio Newsfile - Mon Jan 6, 2:22AM CST

Vancouver, British Columbia--(Newsfile Corp. - January 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence Arranges Financing Newsfile - Tue Dec 31, 2024

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence Announces Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Its Board of Directors Newsfile - Fri Dec 20, 2024

Vancouver, British Columbia--(Newsfile Corp. - December 20, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence Provides Update on Delivery of AGSM Proxy Materials Newsfile - Mon Dec 2, 2024

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence's Proprietary Accum Technology Ready to License to Companies Developing Antibody Drug Conjugates (ADC) Newsfile - Fri Nov 29, 2024

Vancouver, British Columbia--(Newsfile Corp. - November 29, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)
Defence Announces Dr. Maxime Parisotto as CSO, Director of Science and Business Development Newsfile - Mon Nov 25, 2024

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.7900 (-11.24%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - Thu Apr 24, 6:30PM CDT
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot